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Abstract
Lujo virus (LUJV) is a novel member of the Arenaviridae family that was first identified in 2008 after an outbreak of severe
hemorrhagic fever (HF). In what was a small but rapidly progressing outbreak, this previously unknown virus was
transmitted from the critically ill index patient to 4 attending healthcare workers. Four persons died during this outbreak, for
a total case fatality of 80% (4/5). The suspected rodent source of the initial exposure to LUJV remains a mystery. Because of
the ease of transmission, high case fatality, and novel nature of LUJV, we sought to establish an animal model of LUJV HF.
Initial attempts in mice failed, but infection of inbred strain 13/N guinea pigs resulted in lethal disease. A total of 41 adult
strain 13/N guinea pigs were infected with either wild-type LUJV or a full-length recombinant LUJV. Results demonstrated
that strain 13/N guinea pigs provide an excellent model of severe and lethal LUJV HF that closely resembles what is known
of the human disease. All infected animals experienced consistent weight loss (3–5% per day) and clinical illness
characterized by ocular discharge, ruffled fur, hunched posture, and lethargy. Uniform lethality occurred by 11–16 days
post-infection. All animals developed disseminated LUJV infection in various organs (liver, spleen, lung, and kidney), and
leukopenia, lymphopenia, thrombocytopenia, coagulopathy, and elevated transaminase levels. Serial euthanasia studies
revealed a temporal pattern of virus dissemination and increasing severity of disease, primarily targeting the liver, spleen,
lungs, and lower gastrointestinal tract. Establishing an animal LUJV model is an important first step towards understanding
the high pathogenicity of LUJV and developing vaccines and antiviral therapeutic drugs for this highly transmissible and
lethal emerging pathogen.
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Introduction
Beginning in the 1930s, novel pathogenic arenaviruses have
been increasingly recognized as emerging threats to human health
[1,2,3,4,5,6,7,8,9,10]. During the 1960s and 1970s, several
previously unknown arenaviruses emerged as a significant public
health threats and causes of a severe and often fatal human
hemorrhagic fever (HF) syndrome. In 2008, Lujo virus (LUJV), a
novel member of the family Arenaviridae, was first identified after an
outbreak of severe HF in southern Africa [11]. During this
outbreak, the index patient was transported by air from Lusaka,
Zambia, to a private hospital in Johannesburg, South Africa, thus
giving the virus its name, Lu-Jo.
The index patient died from the infection approximately 12
days after the onset of the presumed first symptoms, and 2 days
after hospitalization in Johannesburg. During transport and
hospitalization of the index patient, a total of 4 health care
workers (3 nurses and 1 janitor) were infected with LUJV. After a
period of 10–13 days of progressively severe illness, 3 of these
individuals died, resulting in a total case fatality of 80% (4/5).
Limited data available from these patients indicated that LUJV
HF was characterized by thrombocytopenia, elevated liver
transaminases, coagulopathy, viral antigen in multiple tissues,
neurological symptoms in some cases, and eventual death. While
the outbreak was small, the ease with which LUJV spread among
the primary, secondary, and tertiary contacts with the index
patient, and the lack of a defined etiology, caused significant
alarm. The viral cause of the outbreak was identified as a novel
arenavirus only after the last case fatality [12]. The suspected
source of exposure of the index patient to LUJV (presumably a
rodent) remains unknown.
The arenaviruses are a large and genetically diverse group of
over 30 viruses broadly divided into New World and Old World
serogroups. They are exclusively rodent-borne, except Tacaribe
virus, which was isolated from a bat [13,14]. Phylogenetically,
LUJV is distinct from both the Old World and New World
arenavirus lineages, and is the sole member of a distinct branch
more closely related to the known Old World arenaviruses [12].
Although many arenaviruses are not pathogenic, a large number
can cause a spectrum of human disease ranging from neurological
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symptoms in pediatric or immunocompromised patients (e.g.,
Lymphocytic choriomeningitis virus, LCMV) [15,16,17,18,19,20],
to hemorrhagic syndromes with high case fatalities (e.g., Lassa
virus (LASV), Junin virus (JUNV), and Machupo, Guanarito,
Chapare, and Sabia viruses) [21,22,23].
All arenaviruses are enveloped particles containing bi-segment-
ed, single-stranded, ambi-sense RNA genomes encoding a total of
4 genes [13]. The large (L) genome segment (,7.2 kb) contains the
viral RNA-dependent RNA polymerase and the multi-functional
Z-protein, an important matrix protein that is also responsible for
virus budding. The small (S) genome segment (3.4 kb) encodes the
viral nucleoprotein (NP) and the glycoprotein precursor (GPC),
which is post-translationally processed into the G1 and G2
structural proteins. Both NP and Z proteins function as viral
virulence factors antagonizing host cell interferon responses by a
variety of mechanisms [21,24,25,26].
Although many experimental vaccine candidates and antiviral
drugs are under development [27,28,29,30], currently the only
available vaccine for any pathogenic arenavirus is the live-
attenuated Candid1 vaccine for JUNV, which is restricted for
use only in high-risk individuals such as laboratorians and those
living in endemic areas [31,32]. The antiviral drug ribavirin has
shown some efficacy in treating LASV and some other arenavi-
ruses, but its side effects limit use to high-risk exposures and severe
cases [33,34]. Due to the unique characteristics of the LUJV
outbreak and the highly novel genomic nature of LUJV, we sought
to establish an animal model capable of developing HF similar to
that observed in the 4 fatal human cases. Establishing a robust
animal model is necessary for further investigating LUJV
pathogenesis, and to provide a system to test potential vaccine
candidates and antiviral therapeutic drugs. Initial experiments
with LUJV infection in 2-day-old newborn and 14-day-old
weanling mice failed to provide a lethal model. This was highly
surprising given the near uniform lethality of pathogenic New
World or Old World arenaviruses in newborn or weanling mice,
respectively [12], and highlights another unique feature of LUJV.
We next attempted to develop a LUJV HF model in guinea pigs
(Cavia porcellus), which have been used since the 1960s as reliable
models for a variety of pathogenic New World and Old World
arenaviruses [35,36,37,38,39,40,41,42,43,44]. The inbred strain
13/N guinea pig is highly susceptible to LASV infection; the
animals develop severe, progressive, and ultimately fatal disease
15–21 days post-infection (PI), showing many pathological changes
that closely mimic Lassa fever in humans [37]. Given their
susceptibility to Old World arenaviruses, we began experiments in
strain 13/N guinea pigs to study LUJV virulence and pathogen-
esis. Here, we report successfully establishing a lethal model of
LUJV HF in strain 13/N guinea pigs infected with either authentic
wild-type or a recombinant full-length reverse genetics-derived
LUJV. This robust and highly uniform animal model will permit
further detailed investigations into the molecular determinants of
LUJV pathogenesis, and provide an in vivo system for testing novel




All work with infectious virus or infected animals was conducted
at the Centers for Disease Control and Prevention (CDC, Atlanta,
Georgia, USA), in a biosafety level 4 laboratory. All laboratorians
and animal handlers adhered to international biosafety practices
appropriate for biosafety level 4, strictly following infection control
practices to prevent cross-contamination between individual
animals. All animals were individually housed in an isolator-
caging system (Thoren Caging, Inc., Hazleton, PA, USA) with a
HEPA-filtered inlet and exhaust air supply.
Ethics statement and animal husbandry
All procedures and experiments described herein were ap-
proved by the CDC Institutional Animal Care and Use
Committee (IACUC) and conducted in strict accordance with
the Guide for the Care and Use of Laboratory Animals [45]. All
animals were housed in a climate-controlled laboratory with a
12 h day/12 h night cycle. The CDC is an Association for
Assessment and Accreditation of Laboratory Animal Care
International (AAALAC) fully accredited research facility. No
human patient derived clinical materials were used in the
completion of these studies.
Mice
A total of 8 litters of pregnant outbred mice were obtained from
a commercial vendor (Charles River Laboratories, Wilmington,
MA, USA). All mice were housed as individual family units, and
supplied a commercially available mouse chow and water ad
libitum. The cage environment was enriched with large amounts of
soft bedding, shredded paper, and cotton nestlets. After infection,
each animal was observed at least once per day, and its health
assessed and scored by experienced CDC veterinarians or animal
health technicians. Animals were humanely euthanized with
isoflurane vapors once clinical illness scores (including, but not
limited to, neurological signs, piloerection, ocular discharge,
weight loss, changes in mentation, ataxia, dehydration, or
dyspnea) indicated that the animal was in distress or in the
terminal stages of disease.
Guinea pigs
A total of 47 strain 13/N guinea pigs (healthy adult males and
females aged 1.0–1.5 years) were obtained from an established
breeding colony located at the University of Iowa (Ames, IA,
USA). All animals were housed individually on deep soft bedding
and given food (commercial guinea pig chow, alfalfa cubes, and
fresh green parsley), and water supplemented with guinea pig
Author Summary
The pathogenic arenaviruses are a diverse group of human
pathogens capable of causing a wide range of human
illness ranging from encephalitis to severe hemorrhagic
fever throughout the New and Old World. In 2008, a
previously unknown virus (now named Lujo virus) caused a
high case fatality outbreak (80%) in southern Africa.
Limited data available from these patients indicated that
LUJV HF was characterized by thrombocytopenia, elevated
liver transaminases, coagulopathy, viral antigen in multiple
tissues, neurological symptoms in some cases, and
eventual death. The source of exposure of the index
patient remains unknown. Due to the unusually high
lethality and rapid human to human spread, we sought to
develop an animal model of Lujo hemorrhagic fever. We
report here that after infection with Lujo virus, Strain 13/N
guinea pigs develop a hemorrhagic fever syndrome similar
to the disease observed in human patients. This animal
model of severe Lujo hemorrhagic fever is a critical first
step to increase our understanding of this highly patho-
genic virus, and to develop anti-viral therapeutics or
experimental vaccines for this new and unique threat to
human health.
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appropriate vitamins ad libitum, following standard laboratory
animal husbandry protocols for guinea pigs. After infection, each
animal was observed at least twice per day, and its health assessed
and scored by experienced CDC veterinarians or animal health
technicians. Animals were humanely euthanized with isoflurane
vapors and sodium pentobarbital (Schering-Plough, Kenilworth,
NJ, USA) at either predetermined times PI, or once clinical illness
scores (including, but not limited to, piloerection, ocular discharge,
weight loss, changes in mentation, ataxia, dehydration, dyspnea,
or hypothermia) indicated that the animal was in the terminal
stages of disease.
Viruses
Wild-type LUJV (wtLUJV) from the Centers for Disease
Control and Prevention Viral Special Pathogens Branch reference
collection was passaged in VERO-E6 cells five times before use. A
full-length recombinant LUJV (recLUJV) was derived from cDNA
plasmids using T7-driven reverse genetics as reported in Bergeron
et al. (manuscript in review). To differentiate recLUJV from wtLUJV,
a few silent (non-coding) nucleotide changes were introduced into
the full-length L segment clones of recLUJV (also described in
Bergeron et al., manuscript in review). For mouse experiments,
wtLASV-Josiah and wtJUNV-XJ13 were prepared and utilized as
described in [46,47]. Prior to use, all virus stocks were titrated and
full-length genomic sequences were verified using standard
techniques as described in [46,47].
Animal infection procedures
Mice. For infection, groups of 10 animals (2 or 14 days old)
were inoculated intracranially with 500 focus-forming units (FFU)
of wtLUJV, wtLASV-Josiah, or wtJUNV-XJ13 in 10 uL of
Dulbecco’s modified Eagle’s medium (DMEM; Invitrogen Corp.,
Grand Island, NY, USA) using a 0.3 mL 29-gauge tuberculin
syringe, or with up to 2.06103 FFU of wtLUJV by either
subcutaneous or intraperitoneal routes following techniques
described in [46,47].
Guinea pigs. For infection, all animals were briefly anesthe-
tized with isoflurane vapors and inoculated intraperitoneally in the
lower right quadrant using a 25-gauge 5/8 inch needle attached to
a 1 mL syringe. All animals were inoculated with 250 uL
containing 1.06105 FFU of either wtLUJV (N = 28) or recLUJV
(N = 13), or with sterile diluent (DMEM, Invitrogen; N = 6). After
infection, all animals were weighed and rectal temperatures taken
daily. Each animal was observed and its health assessed and scored
by experienced CDC veterinarians or animal health technicians at
least twice per day. The experiment was conducted in 2 phases: 1)
to assess the overall lethality of wtLUJV or recLUJV infection,
groups of 10 animals were infected and monitored at least twice
daily until found dead or euthanized according to a predetermined
euthanasia/clinical illness scoring algorithm indicating severe
disease or moribundity; and 2) a serial euthanasia phase was
conducted to more closely follow the kinetics of LUJV dissemi-
nation and pathology. To accomplish the second phase, groups of
3 animals were scheduled for euthanasia at 2, 5, 7, 9, 12, or 14
days PI with wtLUJV, and at day 9 PI with recLUJV. Due to
greater than expected virulence of LUJV, the actual days of serial
euthanasia and specimen collection were modified as follows: day
2, N = 3; day 5, N = 3; day 7, N = 3; day 9, N = 3 wt, N = 3 rec;
day 12, N = 3; day 14, N = 2. Two moribund animals from the
serial euthanasia phase were euthanized on day 11 and were
considered as terminal cases; the data from these animals was
combined with data collected from the first phase of the
experiment. The sham-inoculated control animals (N = 6) were
euthanized at the end of the study, approximately 21 days post-
inoculation.
Total RNA extraction
Specimens of liver, lung, spleen, kidney, whole blood, urine,
and/or pleural effusion or abdominal fluid (if present) were
collected sterilely at 2, 5, 7, 9, 12, and 14 days PI, and from
moribund animals that reached experimental end-points. For
RNA extraction, approximately 100 mg specimens of tissues were
stored in RNA extraction buffer (Tripure, Roche Diagnostics,
Indianapolis, IN, USA) at 280uC until homogenization in a high-
throughput tissue grinder (Genogrinder2000, BT&C Inc., Leba-
non, NJ, USA). An equal volume of molecular grade chloroform
was added to each specimen homogenate and vortexed. After a
10 minute spin at .10,000 rpm in a microcentrifuge, the
supernatant was collected and an equal volume of 70% ethanol
was added. The supernatant and ethanol was used for total RNA
extraction (RNAeasy 96 platform, Qiagen, Valencia, CA, USA)
following the manufacturer’s recommended protocols.
Viremia testing by quantitative reverse transcription PCR
(qRT-PCR)
Briefly, LUJV RNA was detected using qRT-PCR with primers
and probe with internal (Zen, Integrated DNA Technologies) and 39
Iowa Black-FQ quencher moieties specific for the NP gene (forward
primer: 59-CTCACACCCACAGGAAAT-39; reverse primer: 59-
GGCCATACATCTCTTCCAGA-39; probe: 59-6FAM-AC-
CCTACAC/Zen/CTCCACAGAACGAAAG-IowaBlackQuench-
erFQ-39). For each viral genome detection reaction, 1 uL of total
RNA was added to a one-step qRT-PCR (Invitrogen), where the first
stand was synthesized using Superscript III at 50uC for 15 min,
denatured at 94uC for 2 min, and amplified for 40 cycles of 94uC for
15 s and 60uC for 1 min (ABI 7500, Life Sciences, Grand Island,
NY, USA). LUJV RNA genome equivalents in infected blood, fluid,
or tissue specimens were quantitated using a standard curve
generated by serial dilutions of a known-titer stock virus spiked into
normal whole guinea pig blood. The results of all qRT-PCR tests
were normalized to endogenous rodent-specific controls (glyceral-
dehyde 3-phosphate dehydrogenase (GAPDH), Invitrogen) follow-
ing the manufacturer’s recommended protocols to account for
sample-to-sample variation in RNA extraction efficiency.
Hematological parameters
Guinea pig whole blood was collected by intracardiac
techniques into either EDTA-coated or heparin-coated vacutainer
tubes. Complete blood counts (CBC) were obtained using the
Hematrue blood analyzer (HESKA, Loveland, CO, USA). Blood
chemistry profiles were obtained from heparinized samples using
either the Piccolo point of care chemistry analyzer (Abaxis, Union
City, CA, USA) or the Hitachi P-module analyzer (Hitachi Hi-
Tech, Tokyo, Japan).
Tissue-specific gene induction qRT-PCR assays
Liver, spleen, lung, and kidney tissues were collected 2, 5, 7, 9,
12, and 14 days PI (serial euthanasia groups), and from moribund
animals that reached experimental end-points of terminal disease.
Specimen RNA was treated with DNase I (Qiagen) followed by
RNA cleanup utilizing the RNeasy Mini columns and wash buffers
(Qiagen) per manufacturer’s recommendations. Total RNA was
quantified after DNase I treatment and cleanup using a NanoDrop
spectrophotometer (Thermo Scientific, Wilmington, DE, USA).
Previously reported gene specific primers were used to detect
interleukin (IL)-1b, IL-2, IL-8, IL-12p40, tumor necrosis factor
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alpha (TNFa), transforming growth factor beta (TGFb), regulated
upon activation normal T-cell expressed and secreted (RANTES),
interferon gamma (IFNg), monocyte chemotactic protein (MCP)-
1, inducible nitric oxide synthetase (iNOS), and GAPDH [48,49].
Generally, 50 ng of RNA was used for each individual qRT-PCR;
however, for samples with low RNA concentrations, a minimum
of 5 ng was used. Invitrogen’s SuperScript III Platinum SYBR
green one-step qRT-PCR kit was used for 25 uL total volume
reactions, with final reaction concentrations of 16 reaction mix,
0.2 M primers, 0.5 uL enzyme mix, and 50 ng RNA. Identical
thermocycling profiles were utilized for all assays; 55uC for
10 min; 95uC for 5 min; amplification for 40 cycles of 95uC for
15 s and 58uC for 30 s; 40uC for 1 min; and a dissociation curve
(CFX96 Touch, Bio-Rad, Hercules, CA, USA). A gene-specific
real-time assay was developed for IL-10 (GenBank accession
JN020146) using the GenScript real-time PCR primer design tool,
IL10 F 59-CACAGGATCAGCTGGACAAC–39, IL10 R 59-
GGGCATCACCTCCACTAGAT-39, and IL10 Probe 59(FAM)-
CCTGGGTTGCCAAGCCTTGTC-(BHQ1)39. The Invitrogen
SuperScript III Platinum one-step qRT-PCR kit was used for
25 mL total volume reactions following the manufacturer’s
protocol and the following thermocycling profile; 55uC for
10 min, 95uC for 2 min, amplification for 40 cycles of 95uC for
15 s and 60uC for 30 s. Guinea pig GAPDH was used as the
internal control calibrator. Bio-Rad CFX manager software v2.1
was used to analyze the cycling threshold (CT) values and melt
curves for each reaction, and results were analyzed using the
comparative CT method as described by Schmittgen and Livak
[50]. The fold change of each serial euthanasia group was
compared to mean fold change of the sham-infected control
guinea pigs (N = 6), and the standard error of the mean was
calculated for each experimental group. Due to technical issues
during RNA extraction, the day 5 PI spleen data was generated
from only 1 infected animal.
Histology
At the time of collection, tissue specimens were fixed in 10%
neutral buffered formalin and gamma-irradiated (2.06106 RAD)
prior to sectioning into 4 um-thick slices and staining with
hematoxylin and eosin following routine histology protocols.
Statistical analyses
All analyses were completed using the PRISM v5.0 program
(Graphpad, LaJolla, CA, USA). Potentially significant differences
between wtLUJV and recLUJV groups were evaluated using a
student’s t-test. In subsequent analyses, wtLUJV and recLUJV
data were combined for all day 9 and terminal group analyses. For
the complete blood counts, clinical chemistry, and gene regulation
data, significant differences between LUJV-infected and sham-
infected animals at each time point were analyzed using a one-way
analysis of variance (ANOVA) with Dunnett’s adjustment for
multiple comparisons (*p,0.05; **p,0.01, ***p,0.001).
Results
LUJV is not virulent in 2-day-old newborn or 14-day-old
weanling mice
Mice were monitored for 28 days PI with 500 FFU of wtLUJV,
wtLASV-Josiah, wtJUNV-XJ13, or inoculation with DMEM as a
negative control. As expected, wtJUNV-XJ13 caused uniform
neurological signs and lethality by 15 days PI in 2-day-old, but not
14-day-old mice. In contrast and as expected, wtLASV infection
resulted in near uniform (90%) lethality in 14-day-old weanling
mice, but was non-lethal in 2-day-old newborn mice. Infection was
confirmed by the detection of anti-Lujo virus specific antibodies at
28 days post-infection in 3 surviving animals. Surprisingly,
wtLUJV did not cause any signs of clinical illness or lethality in
either 2-day-old or 14-day-old mice regardless of the dose (up to
2.06103 FFU) or inoculation route (intracranial, subcutaneous, or
intraperitoneal) (Fig. S1 and data not shown).
LUJV causes severe disease and lethality in adult male
and female strain 13/N guinea pigs
Clinical presentation. All animals infected with either the
wtLUJV (N = 28 total; full-duration disease monitoring group
N = 10; serial euthanasia group N = 18) or with recLUJV (N = 13
total; full-duration disease monitoring group N = 10; serial
euthanasia group N = 3) experienced an onset of progressive
illness starting approximately 5 days PI. The illness was
characterized clinically by pyrexia, loss of body weight, bilateral,
encrusted, light tan-colored ocular discharge, dehydration (as
demonstrated by sunken eyes and tacky mucous membranes),
ruffled fur, piloerection, lethargy, hematuria, frank external
genitourinary hemorrhage (in 1 animal), and eventual moribundity
followed rapidly by death (Fig. 1A). Animals were either found
dead (wtLUJV N = 1; recLUJV N = 2) or euthanized when
moribund (wtLUJV N = 9; recLUJV N = 8) 11–16 days PI
(Fig. 1A). No sham-infected control animals (N = 6) developed
any signs of clinical illness during the duration of the experiment.
Body temperatures. Starting at 5–6 days PI with both
wtLUJV or recLUJV, the animals uniformly developed a febrile
response ranging from a mean of 39.6uC on day 5 PI to a peak of
42.1uC on day 11 PI (Fig. 1B). Individual animal temperatures
often exceeded 42.0uC on days 11 and 12 PI (data not shown).
The febrile response was maintained until immediately prior to
moribundity and death, when body temperatures rapidly declined
to values below normal (data not shown). As a group, the sham-
infected animals maintained body temperatures in the normal
range (37.5–39.5uC).
Weight loss. By day 6 PI, the majority of LUJV-infected
animals began to lose weight, with all animals demonstrating at
least 5% body mass loss by day 7 PI (Fig. 1C). Individual animal
weight loss ranged from 4 to 5% per day until found moribund or
dead by 15 days PI. The weight loss in several animals appeared to
follow a biphasic pattern of 10–15% loss 5–8 days PI, a period of
moderate stabilization for 2–3 days, and a final decline in body
weight 12–15 days PI (Fig. 1C). All sham-infected controls
maintained body weight within 65% of starting weight through-
out the duration of the experiment.
Viral loads in tissues and fluids. Within 48 h PI, a
dramatic rise in viral load, measured by qRT-PCR and reported
as tissue culture infective dose 50 (TCID50) equivalents (eq), was
detected in all tissues and fluids analyzed (whole blood: 4.646102
eq; liver: 1.836105 eq; spleen: 8.136104 eq; lung: 6.226103 eq;
kidney: 5.246103 eq; urine: 2.206103 eq) (Fig. 2). Over the
duration of the experiment, a temporal pattern emerged,
suggesting the liver and spleen as initial sites of high-level viral
replication (2–9 days PI), with increasing amounts of virus detected
in lungs and kidneys 12 and 14 days PI, and in all terminal cases
exceeding 1.06106 eq. Overall, wtLUJV and recLUJV rapidly
caused disseminated infection of various visceral organs, with high
viral loads detected throughout the experiment. Viral loads in
blood, abdominal fluid, and pleural effusions collected from
terminally ill animals were also positive for viral RNA, with titers
ranging from 2.986104 TCID50 eq to .1.0610
5 TCID50 eq by
day 5 and throughout the remainder of the experiment.
Hematology. Automated differential complete blood counts
were conducted on groups of 3 animals at days 2, 5, 7, 9, 12, or 14
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PI with wtLUJV; day 9 PI with recLUJV; and on moribund
animals (N = 9 wtLUJV; N = 8 recLUJV) (Fig. 3). No significant
differences were detected between animals infected with wtLUJV
or recLUJV (Fig. 3 and data not shown); therefore all data from
wtLUJV and recLUJV animals were combined. We observed a
transient but marked left-shift inflammatory response starting at
day 5 PI and continuing through day 7 PI. This response was
characterized by a significant marked leukocytosis (Fig. 3A; mean
12.66103 uL21; reference range (REF) = 9.96103 uL21630%),
and a significant marked non-degenerative granulocytosis (Fig. 3C;
mean 11.96103 uL21; REF = 3.16103 uL21650%). By 9–14
days PI, the animals developed a mild leukopenia that persisted
until moribundity. A moderate to marked lymphopenia was
observed starting on day 5 PI (Fig. 3B, p,0.001; mean
0.46103 uL21; REF = 2.76103 uL21630%) and continuing for
the duration of the experiment. Differential counts revealed a shift
in lymphocyte/neutrophil percentages from 46.7%/43.8% in
normal control animals to an observed maximum shift of 5.5%/
92.3% 7 days PI (data not shown). Mild but non-significant
(p.0.05) decreases in monocytes were observed during the course
of the experiment (Fig. 3D). During the initial stages of infection,
platelets were mildly elevated within the expected normal range 2,
5, and 7 days PI (Fig. 3E; REF = 250–8506103 uL21). However,
by 12 and 14 days PI, and in terminal stage animals, moderate to
marked thrombocytopenia was observed (Fig. 3E; ranging 99–
1636106 uL21). During the course of infection, we observed mild
anemia with concomitant declines in hematocrit (Fig. 3F),
hemoglobin, and total red blood cells (data not shown). The most
severely affected animal was euthanized on day 16 PI with massive
frank hemorrhage in the peritoneal cavity, pan-leukopenia (total
white blood cell count = 3.86103 uL21), marked thrombocytope-
nia (996103 uL21), and profound anemia with a hematocrit of
10.1% (REF = 43612%).
Blood chemistry. Comprehensive blood chemistry analyses
were completed using lithium-heparinized whole blood (Fig. 4).
Electrolytes (sodium, potassium, chloride, and calcium) levels
remained within the normal reference ranges at all timepoints
regardless of the day PI or virus (wtLUJV or recLUJV) used. In
moribund animals euthanized at the terminal stages of disease, a
mild but significant hypoproteinemia (Fig. 4A; mean 4.0 g/dL;
REF = 4.5–5.9 g/dL) and hypoalbuminemia (data not shown;
mean 1.9 g/dL; REF = 2.3–3.0 g/dL) were observed. A consistent
but non-significant and mild elevation in tissue transaminases
(aspartate transferase, alkaline phosphatase, and alanine transfer-
ase; REF,60 IU/L) was detected late in the course of the disease,
with levels highest on day 9 PI (Fig. 4B–D). Normal to moderate
elevations of blood-urea nitrogen (approaching 60 mg/dL;
REF = 15.7–31.5 mg/dL), and very mild or no elevation in
creatinine levels (mean 0.5 mg/dL; REF,0.5 mg/dL) were
observed, consistent with pre-renal azotemia, dehydration, extra-
vascular hemolysis, and/or intra-intestinal hemorrhage.
Necropsy anatomical findings. No animal displayed overt
signs of gross tissue pathology until 7 days PI. Starting at day 7 PI,
liver tissues became progressively more pale and friable, and
demonstrated enhanced reticular patterns of reddening suggestive
of locally extensive to diffuse hepatic congestion; these signs
persisted through day 14 PI or to the point of moribundity or
death (Fig. 5A). By 11–12 days PI, we observed well-demarcated,
multifocal pale foci with a hyperemic rim of hepatic parenchyma.
On or after day 14 PI, we visualized large, locally extensive pan-
lobular areas of pale, grossly necrotic tissue with a hyperemic rim
of tissue, often adjacent to portal veins (Figs. 5B and 5C).
Strikingly, starting 5 days PI and continuing through the course of
the disease, animals developed accumulations of abdominal fluid
Figure 1. Clinical outcomes. A. Survival times of guinea pigs
inoculated with either wild-type Lujo virus (wtLUJV), recombinant LUJV
(recLUJV), or sham DMEM controls. Mean survival times of animals
infected with wtLUJV and recLUJV were not significantly different. B.
Body temperatures (rectal) depicted by group per day post-infection
(PI) or post-sham inoculation. Groupwise means 61 standard error of
the mean (SEM) are depicted. C. Percent (%) change in body mass by
group per day PI or after sham inoculation. In all panels, asterisks depict
the day of the onset of detectable clinical signs (ocular discharge). All
data were normalized to an average starting weight days 25 to 0 pre-
infection. wtLUJV = dark blue circle; recLUJV = open red box; sham
controls = closed grey triangle.
doi:10.1371/journal.pntd.0001801.g001
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(ascites) ranging in character from 1.0–2.0 mL of clear to pale
yellow transudate on day 5, to moderate volumes (5.0–9.0 mL) of
serosanguineous fluid 9–12 days PI, to frank blood that, in the
most extreme example, exceeded 35.0 mL on day 16 PI (Fig. 5D).
Mesenteric, ileocecocolic, and mediastinal lymph nodes became
severely congested and hemorrhagic by 9 days PI (Fig. 5E).
Generally, by day 9 PI and all subsequent time points, distention
of the small bowel (jejunum), and evidence of hemorrhage on the
mucosal and serosal surfaces of the large bowel (distal cecum) were
observed (Fig. 5F). Starting on day 12 PI, approximately 50% of
the animals had moderately to severely enlarged and flaccid hearts
with thinning of the right ventricular wall. The most severely
affected animals had a severely distended right ventricle wall
grossly consistent with dilated cardiomyopathy (Fig. 5G). Signs of
gross kidney pathology were observed after 12 days PI as a
hyperemic rim at the junction of the renal cortex and medullary
junction. In most cases, by day 14 PI and in terminal animals, the
bladder of infected animals was filled with a dark fluid consistent
with hematuria and contained multiple petechia on the serosal and
mucosal surface (Figs. 5H and 5I). Consistently, animals in the
terminal stages of LUJV induced disease developed multiple gross
anatomical signs of profound coagulopathy suggestive of HF and
bleeding diatheses.
Histological findings. We examined a broad array of tissue
specimens collected from guinea pigs 2, 5, 7, 9, or 14 days PI and
from terminal cases (Fig. 6). The most consistently observed lesions
among LUJV-infected animals were hepatocyte and myocardial
necrosis. No significant differences in lesion occurrence or severity
were found between animals infected with wtLUJV or recLUJV.
Except in terminally ill cases, the hepatic necrotic areas were
usually minute, affecting only a few (,20) hepatocytes. A mixed
(heterophilic and lymphohistioplasmacytic) inflammatory infiltrate
was usually admixed with necrotic hepatocytes (Fig. 6A). Gener-
ally, a pattern of multifocal hepatic necrosis and multifocal
centrilobular hepatocellular macrovesiculation was observed by
day 5 PI. During the course of the serial euthanasia experiment
liver lesions generally became more pronounced and were
classified histologically as either normal (1/15), minimal (n = 5/
15), mild (n = 4/15), or moderate (3/15). Hepatic infarction was
found in 3 of the 4 terminally ill animals (Fig. 6B). Despite the
presence in these animals of locally extensive histologic evidence of
liver necrosis and fibrin deposition, the liver enzyme activities in
the sera of affected guinea pigs were consistently only moderately
elevated. No significant differences were found between males and
females in hepatic necrosis. The degree of hepatic necrosis was
similar among non-terminal animals 5–9 days PI.
Most infected guinea pigs also developed minimal to mild
myocardial necrosis with or without a histiocytic inflammatory
response (Fig. 6C). Three animals developed marked lymphoplas-
macytic myocarditis; 2 of these animals were terminally ill, 1 with
hepatic infarction. One guinea pig incidentally had mucoid
degeneration of the left atrioventricular valve (endocardiosis),
usually encountered in older animals.
The kidneys of most animals were also affected. Most kidneys
showed tubular degeneration, with or without mineralization and
varying (usually mild) degree of interstitial lymphoplasmacytic
infiltrates. Tubular degeneration was most likely due to LUJV
infection. However, it is unclear if the interstitial inflammation was
related to LUJV infection or was an incidental finding.
In addition to hepatic necrosis, myocarditis, and kidney
pathology, the most severely affected animals developed other
histologic lesions, including focal mild cortical cell necrosis in the
adrenal gland, hemosiderin-laden macrophages, and erythro-
phagocytosis in mesenteric lymph nodes (Fig. 6D).
Generally, specimens from the lung, spleen, skeletal muscle,
uterine horn or testes, adrenal gland, and urinary bladder
appeared normal by routine hematoxylin and eosin histology.
Other incidental findings not directly related to LUJV infection
included mild to moderate focal endometritis (2 animals), and a
small basal cell tumor in the stomach wall of one animal.
Tissue-specific gene induction. Specimens of liver, lung,
spleen, and kidney were collected 2, 5, 7, 9, 12, or 14 days PI, from
terminal endpoint animals, and from sham-inoculated controls.
Relative quantities of IL-1b, IL-2, IL-8, IL-10, IL-12p40, IFNg,
MCP-1, iNOS, RANTES, TNFa, and TGFb mRNA, normalized
to GAPDH, were analyzed by qRT-PCR. These were compared
as groups between LUJV-infected and sham-inoculated control
animals (Fig. 7 and Table S1). No significant difference in the
magnitude of gene fold-changes was detected between wtLUJV
and recLUJV infected animals, so all data from these animals were
combined. Generally, we saw significant differences in the
magnitude of gene induction across tissue types, with lung, kidney,
Figure 2. Viral RNA load. Viral RNA loads (qRT-PCR-derived tissue culture infective dose 50 (TCID50) equivalents) in blood, liver, spleen, lungs, and
kidney are shown.
doi:10.1371/journal.pntd.0001801.g002
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and liver tissues all demonstrating greater fold-changes compared
to spleen tissues regardless of the time PI. Broadly, we observed no
change or decrease (2 to 5-fold) in several pro-inflammatory
mRNA levels (IL-1b, RANTES), and modest up-regulation of
TNFa (2 to 7-fold), primarily in kidneys. Most prominently, IFNg
was elevated in all tissues, ranging from an approximately 15-fold
increase on day 5 PI to .100 fold-increase at day 14 PI. Similarly,
rises in MCP-1 gene activity were detected primarily in liver,
peaking at .53-fold in terminal animals. IL-8 (a potent activator
of neutrophils and other granulocytes) was upregulated (.11-fold
at day 5 PI; .21 fold in terminal cases) in the liver. Only modest
upregulation of IL-12p40 was detected in kidneys and lungs.
Generally, we noted an induction of the anti-inflammatory/
immunoregulatory gene IL-10 in all tissues, including .15-fold
induction in lungs of LUJV-infected animals compared to control
animals at day 14 PI (Fig. 7 and Table S1). In contrast, TGFb
(another immunosuppressive mediator) was slightly reduced, but
only in the spleen. Specific gene mRNA signatures for IL-2 and
iNOS were not detected in any tissue at any time.
Discussion
The pathogenic arenaviruses are genetically diverse, globally
distributed, and capable of causing human illness ranging from
encephalitis to severe and often lethal HF. Divided into New
World and Old World lineages, these rodent-borne viruses are
most often transmitted to humans by direct contact or aerosol
exposure to infectious rodent excreta, or, in some cases, via a chain
of human-to-human transmissions within hospital settings. The
overall public health impact can range from only a few cases (e.g.,
Sabia or Chapare viruses) to over 100,000 cases per year (e.g.,
LASV) [22,51]. LUJV is the most recently discovered pathogenic
Figure 3. Complete blood counts. Individual animal blood cell parameters. In all panels, each animal’s data are depicted along with the
groupwise mean (horizontal bar) 61 SEM (error bars). Panel A. Leukocytes, B. Granulocytes, C. Lymphocytes, D. Monocytes, E. Platelets, and F.
Hematocrit are depicted. Significant deviations from normal control animal values are indicated by asterisks (p-value: *,0.05; ***,0.001).
wtLUJV = dark blue circle; recLUJV = open red box; sham controls = closed grey triangle.
doi:10.1371/journal.pntd.0001801.g003
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arenavirus, identified in 2008 after a high fatality (80%) cluster of
cases among primary, secondary, and tertiary contacts with the
index patient [52].
A number of factors mark LUJV as a unique arenavirus.
Although the data from the 2008 outbreak are limited, the high
case fatality was striking compared with most other arenavirus
outbreaks that typically are associated with case fatalities of 10–
40% [53,54]. Phylogenetically, LUJV is distinct from all previously
identified arenaviruses, forming a unique lineage more closely
related to the Old World than New World arenaviruses, but with
over 40% divergence from LASV at the nucleotide level [12]. The
unique genomic sequence and high antigenic diversity compared
to other Old World and New World arenaviruses greatly
complicated its initial diagnosis by molecular (RT-PCR) or
serology (IgM/IgG) techniques [11]. Unfortunately, due to these
and other factors, the virus later named LUJV was only identified
as the specific cause of the 2008 outbreak several weeks after the
last fatal case of Lujo HF.
To assess the in vivo characteristics of LUJV, we began with the
traditional newborn and weanling outbred mouse models of
arenavirus infection [12]. These experiments further demonstrated
the unique virulence properties of LUJV compared to New World
(JUNV-XJ13) and Old World (LASV-Josiah) prototype arenavi-
ruses. Both JUNV and LASV are highly virulent in newborn and
weanling mice, respectively, causing lethality in an age-dependent
pattern [12,46,47,55]. In previous experiments, JUNV dosages as
low as 1.06101 FFU caused uniform lethality after intracranial
inoculation into 2-day-old mice (data not shown). Similar dosages
of LASV were lethal in 14-day-old mice (data not shown).
However, LUJV was non-lethal in mice regardless of the route of
inoculation (intracranial, subcutaneous, or intra-peritoneal),
mouse age at inoculation (2 or 14 days old), or viral dose (ranging
Figure 4. Comprehensive serum chemistry analyzes. A. Total Protein, B. Aspartate transferase (AST), C. Alanine transferase (ALT), D. Alkaline
phosphatase (ALP), E. Blood urea nitrogen (BUN) and F. Creatinine. In all panels, each animal’s data are depicted along with the groupwise mean
(horizontal bar) 61 SEM (error bars). Significant deviations from normal control animal values are indicated by asterisks (p-value: *,0.05; **,0.01;
***,0.001). wtLUJV = dark blue circle; recLUJV = open red box; sham controls = closed grey triangle.
doi:10.1371/journal.pntd.0001801.g004
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up to the maximum dose tested, 2.06103 FFU; Fig. S1, and data
not shown).
In marked contrast with the mouse results, LUJV caused severe,
rapidly progressive, and uniformly lethal and hemorrhagic disease
in strain 13/N guinea pigs. In this model, we observed an
apparent incubation period of 5 to 6 days from the time of
inoculation to the first clinical signs of illness (fever and weight
loss). Over the next 24 to 48 h, the animals began to display signs
of progressive illness (bilateral ocular discharge, continued fever,
weight loss, and dehydration) until they were found dead or
humanely euthanized when moribund. By day 5 PI, significant
hematological changes began to occur, including hypoprotein-
emia, thrombocytopenia, and lymphopenia (Fig. 3). Interestingly,
although we saw consistent elevation in key serum transaminase
Figure 5. Necropsy gross anatomical findings. A. Whole liver from terminally infected animal. Note the marked congestion and extensive pan-
lobular zone of hepatic damage due to infarction near the liver hilus that is surrounded by a well-demarcated hyperemic rim of hepatic parenchyma
(arrow). B. Cross-section of the liver in panel A at the level of the main portal vein through the center of a zone of hepatic necrosis and infarction
(asterisk). C. Another example of the severe hepatic congestion, necrosis, and infarction observed in all terminal cases (arrow). D. Frank hemorrhage
(.35 mL) in the abdominal cavity. E. Severely congested and hemorrhagic mesenteric lymph nodes (asterisks), and severe congestion and
hemorrhage on the serosal surface of the cecum (arrows). F. Mucosal surface of the cecum in panel E; note the severe congestion and extensive
petechiation. G. Example of the severe dilated cardiomyopathy observed in the majority of infected animals beginning at approximately day 12 PI. H.
Serosal surface of the bladder; note the severe petechiation. I. Contents of the bladder in panel H, consistent with hematuria and frank hemorrhage
collected in situ by cystocentesis. Panels A, B, C, G, H (wtLUJV infected). Panels D, E, F (recLUJV infected).
doi:10.1371/journal.pntd.0001801.g005
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enzyme (aspartate transferase, alkaline phosphatase, and alanine
transferase) activities, these were neither dramatic nor statistically
significant and are typical of the generally poor release of tissue
transaminases in guinea pigs in the face of tissue damage or
necrosis. Subjective comparisons of clinical illness severity, and
gross and histologic pathology between guinea pigs infected with
LUJV or LASV suggests that LUJV caused a more profound
illness (greater and more rapid weight loss, and frank hemorrhage
and congestion in gastrointestinal organs, bladder, lymph nodes,
and abdominal cavity), tissue damage (hepatic and myocardial
necrosis), and hallmarks that may be consistent with disseminated
intravascular coagulation (DIC) than LASV in preliminary
experiments completed in our laboratory and as reported in [37]
(Figs. 5 and 6, and data not shown).
Previous studies of human pathogenic New World (JUNV,
Guanarito (GTOV), Machupo (MACV)) and Old World (LASV)
arenaviruses using rodents and other small animal models failed to
demonstrate clear consistent signs of HF (reviewed in [56]). LUJV
infection of guinea pigs, however, resulted in severe infarction,
fibrin deposition, and hemorrhage in multiple organs, suggesting
DIC. The progressive reductions in platelet numbers (9, 12, and
14 days PI) are consistent with the consumption of platelets at sites
of localized virus inflammation and tissue destruction, or, in the
most extreme cases, may be consistent with DIC at later time
points PI. Anecdotally, the animal with severe frank hemorrhage
into the abdominal cavity developed profound thrombocytopenia
(996103 uL21). Unfortunately, no assays to determine coagulation
factor parameters (i.e., activated partial thromboplastin time
(APTT) or prothrombin time (PT)) were completed to directly
assess the influence of these coagulation pathways on the observed
coagulopathy. It is clear that further work is essential to definitively
characterize the underlying mechanisms of these observations
before firm conclusions can be drawn. For these types of studies
this guinea pig model may provide a potentially useful alternative
Figure 6. Histological findings. A. High-magnification photomicrograph of a liver from a guinea pig infected with LUJV. The center is composed
of necrotic hepatocytes admixed with cellular debris, and is surrounded by moderate numbers of histiocytes. Hematoxylin and eosin stain; 2006
original magnification; scale bar = 50 mm. B. Low magnification photomicrograph of the interface of normal (N) and infarcted (I) area of the liver from
a guinea pig with LUJV infection. The infarcted area is cell-poor, and inflammatory cell reaction (arrow) is observed at the interface. Hematoxylin and
eosin stain; 1006 original magnification; scale bar = 100 mm. C. High-magnification photomicrograph of the papillary muscles of the heart from a
guinea pig with LUJV infection. The muscle fibers (solid arrows) are slightly swollen and hypereosinophilic. Small nests of mononuclear inflammatory
cells (dashed arrow) separate the myofibers. Hematoxylin and eosin stain; 2006 original magnification; scale bar = 50 mm. D. High magnification
photomicrograph of the mesenteric lymph-node from a guinea pig infected with Lujo virus (terminal case). The medullary sinuses are filled with large
numbers of erythrocytes and there are scattered macrophages that contain intracytoplasmic erythrocytes (erythrophagocytosis, arrows). This lesion is
compatible with a prior hemorrhage in the drainage area of the mesenteric lymph-node. Hematoxylin and eosin stain, 4006original magnification,
scale bar = 20 mm. Panels A, B, C, D (wtLUJV) infected.
doi:10.1371/journal.pntd.0001801.g006
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to non-human primate models for studying basic pathogenesis of a
bona fide human pathogenic arenavirus causing severe coagulop-
athy and HF.
The rapid rise and magnitude of LUJV-specific antigen
deposition, histologic pathology, and RNA titers in tissues, blood,
urine, and abdominal fluid were surprising. Within 48 h of
infection, the virus already disseminated to the liver, spleen,
kidneys, and lungs, and was rapidly replicating up to 1.86105
TCID50 eq/g of liver. Interestingly, this high-titer replication
continued for another 48–72 h before the onset of illness,
indicated by increased body temperature and weight loss 5–6
days PI. Tissue viral loads remained extremely high throughout
the course of the disease, with death occurring 11–16 days PI.
Like other arenaviruses, LUJV broadly modulates host immune
responses during infection. The molecular basis of the seemingly
high LUJV virulence in humans has not been characterized.
However, recent work using reverse genetics-derived recombinant
viruses indicates that LUJV has unique promoter elements that
influence the expression of the viral NP and glycoprotein, and an
unusually long intergenic region sequence on the viral L segment,
which influences expression of the Z protein (Bergeron et al., in-
review). Both LASV and lymphocytic choriomeningitis virus NP
and Z proteins have immunomodulatory properties and function
as potent antagonists of host cell antiviral responses ([21,24,25,26]
and reviewed in [57]). These and other yet unrecognized
molecular motifs may augment the apparently enhanced virulence
of LUJV by increasing viral replication or interfering with
immunoregulatory mechanisms within the host.
The ability of LUJV to influence the immune response is
illustrated in guinea pigs by the finding that, despite the very high
viral loads by day 5 PI, pro-inflammatory cytokine/chemokine
genes, such as IL-1b and RANTES, were downregulated 2–4-fold
early during infection (Fig. 7). In contrast, as early as day 5 PI,
potent mediators of macrophage and neutrophil activation and
inflammation (IL-8, MCP-1) and pro-inflammatory molecules (IL-
12p40, and IFNg) were transcriptionally upregulated (10 to .100-
fold) compared to mock inoculated animals, especially in liver and
kidney tissues (Fig. 7, and Table S1). Potentially important and
robust induction of the broad immunomodulatory mediator IL-10
was also detected in lungs by day 9 PI, and may signal attempts to
limit and control pro-inflammatory activity, allowing for further
virus replication.
Overall, the pattern of gene induction and histological evidence
from our study allow for the speculation that, in early stages of
infection, the animals mounted a pro-inflammatory and innate
immune response (presumably involving macrophages, neutro-
phils, NK-cells (i.e., Kurloff cells in the guinea pig), and/or NKT-
cells) in multiple tissues. This was followed by a predominantly
Th1 response dominated by IFNg, MCP-1, and IL-12p40, which
likely stimulated activation and enhanced function presumably of
NK cells, CD4+ TH1 cells, and/or CD8+ cytotoxic lymphocytes,
resulting in a strong bias towards cell mediated immunity. Since
LUJV is not highly cytopathic in cell culture, these responses may
have been more deleterious than helpful to the host, due to
immune cell-mediated destruction of vital organs. This hypothesis
is consistent with recent work describing enhanced LASV
Figure 7. Immune mediator mRNA regulation. Heat map
depicting the fold-increase or fold-decrease of mRNA from visceral
tissues of infected animals compared to tissues from mock-inoculated
animals. Deep blue reflects maximal fold-decrease detected (approxi-
mately 25 fold). Increasingly intensity of pale yellow to orange to red
indicates range of fold-increase from +5 to a maximum of approx-
imately +101 fold in IFNu at day 14 PI and in terminal cases. Fold-
changes between 22 and +2 are depicted in white. Heat map
generated with free downloadable software available from the Broad
Institute (GENE-E Array, http://www.broadinstitute.org/cancer/software/
GENE-E/).
doi:10.1371/journal.pntd.0001801.g007
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pathogenesis due to deleterious T-cell mediated activation and
stimulation of monocytes/macrophages, leading to tissue destruc-
tion in humanized HHD mice [58]. Regardless of the immune
mechanisms stimulated by LUJV infection, these responses were
insufficient to control virus replication and dissemination through-
out the host, and to prevent eventual lethality.
Similarly to LASV infection in humans and non-human primate
animal models, LUJV does not appear, at least at the mRNA
transcriptional level, to elucidate an end-stage cytokine storm as
seen in fatal hemorrhagic cases of infection with Ebola, Marburg,
or Rift Valley fever viruses [59,60,61,62]. Although IFNu-
producing cells (presumably natural killer cells, NKT-cells, and/
or macrophages) are clearly activated, the increase in mRNA
encoding the TNFa, iNOS, and IL-1b genes was not significant
even in terminal cases. Among the limited genes analyzed in this
study, we speculate that complete dysregulation of the host
immune response is not responsible for the dramatic vascular
permeability changes and coagulopathy observed in the guinea pig
model of LUJV HF. Although our results are suggestive, more
definitive studies of the guinea pig immune response are necessary
before drawing distinct conclusions regarding the roles of
inflammatory mediators, immune effector cells, and viral virulence
factors in the pathogenesis of LUJV HF in this animal model.
The dramatic severity of the clinical illness, short survival times,
high tissue viral loads, and the mRNA gene expression patterns in
visceral organs further highlight the unique pathogenic character-
istics of LUJV compared with other studies of LASV or JUNV
[37,44]. Our in vivo data, taken together with recent insights into the
unique genomic elements regulating viral replication in cell culture,
stress the importance of further work to elucidate the possibly novel
pathogenic mechanisms employed by LUJV to cause HF in both
humans and guinea pigs. Direct comparisons of the precise
pathogenic mechanisms utilized by LUJV and other pathogenic
arenaviruses are underway, and may reveal insights into the
apparent enhanced virulence of LUJV in humans and guinea pigs,
and provide broader understanding of arenavirus HF. Regardless of
the exact mechanisms, LUJV is clearly highly pathogenic, easily
transmitted in health care settings, and a potential health threat in
southern Africa. Establishing a robust and reliable animal model of
severe and lethal LUJV HF is a critical first step for further
investigations to increase our understanding of LUJV and for
developing anti-viral therapeutics or experimental vaccines for this
new and unique threat to human health.
Supporting Information
Figure S1 Clinical outcomes (mice). Survival times of
newborn 2-day-old (panel A) and weanling 14-day-old mice (panel
B) inoculated with equivalent amounts (500 FFU) of wtLUJV,
wtJUNV-XJ13, or wtLASV-Josiah intracranially. Note that no
LUJV-infected or sham-inoculated animals succumbed during the
28-day monitoring period.
(EPS)
Table S1 Gene induction data. Fold-change of selected
mRNA genes in liver, lung, spleen and kidney tissues from LUJV-
infected guinea pigs over those of sham-inoculated animals. Data
shown is the groupwise average, standard error of the mean (SEM)
and significance. Significant deviations from normal control
animal values are indicated by asterisks (p-value: *,0.05;
**,0.01; ***,0.001 and ns = not significant.
(EPS)
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